KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Deferred Taxes (2022 - 2025)

Historic Deferred Taxes for Neogenomics (NEO) over the last 4 years, with Q3 2025 value amounting to -$869000.0.

  • Neogenomics' Deferred Taxes fell 45614.75% to -$869000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 3324.32%. This contributed to the annual value of $3.1 million for FY2024, which is 7257.21% down from last year.
  • Per Neogenomics' latest filing, its Deferred Taxes stood at -$869000.0 for Q3 2025, which was down 45614.75% from $993000.0 recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Deferred Taxes registered a high of $5.7 million during Q2 2022, and its lowest value of -$869000.0 during Q3 2025.
  • For the 4-year period, Neogenomics' Deferred Taxes averaged around $2.1 million, with its median value being $1.8 million (2023).
  • Within the past 5 years, the most significant YoY rise in Neogenomics' Deferred Taxes was 10905.26% (2025), while the steepest drop was 45614.75% (2025).
  • Over the past 4 years, Neogenomics' Deferred Taxes (Quarter) stood at $3.3 million in 2022, then plummeted by 45.34% to $1.8 million in 2023, then fell by 14.18% to $1.6 million in 2024, then crashed by 155.85% to -$869000.0 in 2025.
  • Its Deferred Taxes stands at -$869000.0 for Q3 2025, versus $993000.0 for Q2 2025 and $541000.0 for Q1 2025.